MedicalSentry

Health Research Company

Ritalin

generic name is methylphenidate hydrochloride

Why is this drug subscribed ?

Methylphenidate is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in adults and children. Methylphenidate (Ritalin, Ritalin SR, Methylin, Methylin ER) is also used to treat narcolepsy (a sleep disorder that causes excessive daytime sleepiness and sudden attacks of sleep). Methylphenidate is in a class of medications called central nervous system (CNS) stimulants. It works by changing the amounts of certain natural substances in the brain.

Active Substance: METHYLPHENIDATE HYDROCHLORIDE

Ritalin Available Drugs :

Ritalin ndc# 54868-2762

by Physicians Total Care, Inc.

ORAL TABLET with active strength of 20 mg/1

started marketing at 10/03/2000 .

Ritalin ndc# 0078-0424

by Novartis Pharmaceuticals Corporation

ORAL CAPSULE, EXTENDED RELEASE with active strength of 10 mg/1

started marketing at 05/06/2002 .

Ritalin ndc# 0078-0442

by Novartis Pharmaceuticals Corporation

ORAL TABLET, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 31/03/1982 .

Ritalin ndc# 0078-0440

by Novartis Pharmaceuticals Corporation

ORAL TABLET with active strength of 10 mg/1

started marketing at 31/12/1955 .

Ritalin ndc# 0078-0441

by Novartis Pharmaceuticals Corporation

ORAL TABLET with active strength of 20 mg/1

started marketing at 31/12/1955 .

Ritalin ndc# 0078-0439

by Novartis Pharmaceuticals Corporation

ORAL TABLET with active strength of 5 mg/1

started marketing at 31/12/1955 .

Ritalin ndc# 0078-0372

by Novartis Pharmaceuticals Corporation

ORAL CAPSULE, EXTENDED RELEASE with active strength of 40 mg/1

started marketing at 05/06/2002 .

Ritalin ndc# 0078-0370

by Novartis Pharmaceuticals Corporation

ORAL CAPSULE, EXTENDED RELEASE with active strength of 20 mg/1

started marketing at 05/06/2002 .

Ritalin ndc# 0078-0371

by Novartis Pharmaceuticals Corporation

ORAL CAPSULE, EXTENDED RELEASE with active strength of 30 mg/1

started marketing at 05/06/2002 .

Ritalin Search Trends:

News :

Social Buzz

comments powered by Disqus